SE8401167L - Indanderivat och salter derav - Google Patents
Indanderivat och salter deravInfo
- Publication number
- SE8401167L SE8401167L SE8401167A SE8401167A SE8401167L SE 8401167 L SE8401167 L SE 8401167L SE 8401167 A SE8401167 A SE 8401167A SE 8401167 A SE8401167 A SE 8401167A SE 8401167 L SE8401167 L SE 8401167L
- Authority
- SE
- Sweden
- Prior art keywords
- group
- agents
- lower alkyl
- substituents
- salts
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 239000003795 chemical substances by application Substances 0.000 abstract 8
- 125000001424 substituent group Chemical group 0.000 abstract 6
- 125000005843 halogen group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- -1 hydroxylimino group Chemical group 0.000 abstract 4
- 125000003392 indanyl group Chemical class C1(CCC2=CC=CC=C12)* 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 230000003449 preventive effect Effects 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000005623 Carcinogenesis Diseases 0.000 abstract 1
- 208000002177 Cataract Diseases 0.000 abstract 1
- 238000009825 accumulation Methods 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000036952 cancer formation Effects 0.000 abstract 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 231100000504 carcinogenesis Toxicity 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000007246 mechanism Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 235000014593 oils and fats Nutrition 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 235000021067 refined food Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/42—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3642983A JPS59161339A (ja) | 1983-03-04 | 1983-03-04 | インダン誘導体 |
JP19026983A JPS6081126A (ja) | 1983-10-11 | 1983-10-11 | 低酸素症改善剤 |
JP24587583A JPS60142919A (ja) | 1983-12-29 | 1983-12-29 | 抗酸化剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8401167D0 SE8401167D0 (sv) | 1984-03-02 |
SE8401167L true SE8401167L (sv) | 1984-09-05 |
SE464194B SE464194B (sv) | 1991-03-18 |
Family
ID=27289096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8401167A SE464194B (sv) | 1983-03-04 | 1984-03-02 | Indanderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner |
Country Status (11)
Country | Link |
---|---|
US (1) | US4792628A (sv) |
KR (1) | KR910003337B1 (sv) |
CA (1) | CA1245663A (sv) |
CH (1) | CH664359A5 (sv) |
DE (1) | DE3407842A1 (sv) |
ES (2) | ES530269A0 (sv) |
FR (1) | FR2569183B1 (sv) |
GB (1) | GB2135999B (sv) |
IT (1) | IT1178868B (sv) |
NL (1) | NL8400711A (sv) |
SE (1) | SE464194B (sv) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6169747A (ja) * | 1984-08-31 | 1986-04-10 | Otsuka Pharmaceut Co Ltd | 2,3―ジヒドロ―1h―インデン誘導体及びその製造法 |
DK575387A (da) * | 1986-11-04 | 1988-05-05 | Otsuka Pharma Co Ltd | Hydrofluorenderivater, fremgangsmaade til fremstilling deraf og praeparater indeholdende saadanne forbindelser |
WO1992021641A1 (en) * | 1991-05-29 | 1992-12-10 | Pfizer Inc. | Dihydroxyindanone tyrosine kinase inhibitors |
US5877218A (en) * | 1994-01-10 | 1999-03-02 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
US5646188A (en) * | 1995-07-05 | 1997-07-08 | Teva Pharmaceutical Industries, Ltd. | Polyamine derivatives of 1-aminoindan |
EP0874059A4 (en) * | 1996-01-12 | 1999-10-27 | Nippon Steel Chemical Co | PROCESSES FOR THE PRODUCTION OF INDAN DERIVATIVES |
PT966435E (pt) | 1996-12-18 | 2005-06-30 | Yissum Res Dev Co | Derivados aminoindano |
DE19749453A1 (de) * | 1997-11-10 | 1999-05-12 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
US6737547B1 (en) | 1998-12-31 | 2004-05-18 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using N-acyl-1H-aminoindenes |
JP2003512426A (ja) | 1999-10-27 | 2003-04-02 | テバ ファーマシューティカル インダストリーズ リミティド | 双極性気分障害における躁病の治療のための1−アミノインダンの使用。 |
US20040010038A1 (en) * | 2002-02-27 | 2004-01-15 | Eran Blaugrund | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
CA2634166C (en) * | 2005-12-09 | 2016-03-29 | Marta Weinstock-Rosin | Use of low-dose ladostigil for neuroprotection |
TW200744576A (en) * | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
TWI578918B (zh) | 2012-05-11 | 2017-04-21 | 三菱瓦斯化學股份有限公司 | 氧吸收劑組成物及氧吸收劑包裝體 |
CN103086834B (zh) * | 2013-01-08 | 2015-05-27 | 上海化工研究院 | 一种联芳基茚类化合物的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2916490A (en) * | 1959-12-08 | Ocjhs | ||
US3709996A (en) * | 1963-08-02 | 1973-01-09 | Aspro Nicholas Ltd | Pharmaceutical compositions containing n-cyclopropyl-1-aminoindane compounds and adapted for administration to obtain inhibition of monoamine oxidase enzyme and process |
US3637740A (en) * | 1969-04-21 | 1972-01-25 | Pfizer | Aminobenzocycloalkane compounds |
FR2456738A2 (fr) * | 1978-04-10 | 1980-12-12 | Delalande Sa | Nouvelles cinnamoyles piperazines et homopiperazines, leur procede de preparation et leur application en therapeutique |
CA1109080A (en) * | 1978-05-30 | 1981-09-15 | Hideo Kato | Indanamine derivatives |
-
1984
- 1984-03-02 CH CH1054/84A patent/CH664359A5/de not_active IP Right Cessation
- 1984-03-02 CA CA000448797A patent/CA1245663A/en not_active Expired
- 1984-03-02 DE DE3407842A patent/DE3407842A1/de not_active Withdrawn
- 1984-03-02 KR KR1019840001068A patent/KR910003337B1/ko not_active IP Right Cessation
- 1984-03-02 SE SE8401167A patent/SE464194B/sv not_active IP Right Cessation
- 1984-03-02 IT IT67205/84A patent/IT1178868B/it active
- 1984-03-02 ES ES530269A patent/ES530269A0/es active Granted
- 1984-03-05 NL NL8400711A patent/NL8400711A/nl not_active Application Discontinuation
- 1984-03-05 FR FR8403398A patent/FR2569183B1/fr not_active Expired
- 1984-03-05 GB GB08405711A patent/GB2135999B/en not_active Expired
-
1985
- 1985-06-17 ES ES544290A patent/ES8604141A1/es not_active Expired
-
1987
- 1987-04-16 US US07/039,779 patent/US4792628A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES8602606A1 (es) | 1985-12-01 |
KR840009060A (ko) | 1984-12-24 |
KR910003337B1 (ko) | 1991-05-27 |
SE464194B (sv) | 1991-03-18 |
SE8401167D0 (sv) | 1984-03-02 |
DE3407842A1 (de) | 1984-09-06 |
ES530269A0 (es) | 1985-12-01 |
GB2135999B (en) | 1987-05-20 |
ES8604141A1 (es) | 1986-01-16 |
FR2569183A1 (fr) | 1986-02-21 |
IT8467205A1 (it) | 1985-09-02 |
NL8400711A (nl) | 1984-10-01 |
GB8405711D0 (en) | 1984-04-11 |
IT8467205A0 (it) | 1984-03-02 |
CH664359A5 (de) | 1988-02-29 |
US4792628A (en) | 1988-12-20 |
CA1245663A (en) | 1988-11-29 |
FR2569183B1 (fr) | 1988-06-24 |
ES544290A0 (es) | 1986-01-16 |
IT1178868B (it) | 1987-09-16 |
GB2135999A (en) | 1984-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8401167D0 (sv) | Indanderivat och salter derav | |
HUP9600448A2 (hu) | Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk | |
HK57197A (en) | Naphthalene derivatives procedure for their preparation and pharmaceutical compositions containing them | |
ES2079520T3 (es) | Nuevos antiepilepticos. | |
HUP0001760A2 (hu) | Aril-acil-piridazin-származékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és a vegyületek alkalmazása gyógyszerkészítmények előállítására | |
NO160920C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazino-pteridin-derivater. | |
JPS5598179A (en) | Novel arylether*its manufacture and drug containing same for treating allergic disease | |
CA1272733C (en) | Compositions for treating glaucoma | |
KR890011596A (ko) | 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도 | |
FR2506306A1 (fr) | Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique | |
MX9203323A (es) | El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales. | |
ES2063513T3 (es) | Nuevos derivados del oxazol, su preparacion y las composiciones farmaceuticas que les contienen. | |
EP0307061B1 (en) | Anxiolytically active piperazine derivatives | |
MX9307079A (es) | Mejoras en composiciones farmaceuticas para el tratamiento de trastornos funcionales de las vias intestinales y mejoras en un procedimiento para la preparacion de dichas composiciones. | |
RU94046320A (ru) | Применение карбоциклически и гетероциклически анеллированных дигидропиридинов и их фармацевтически приемлемых солей в качестве средства для защиты головного мозга, лечения хронических воспалительных процессов и торможения свертывания крови или агрегации тромбоцитов | |
FR2782515B1 (fr) | NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT | |
IL66804A0 (en) | 2-amino-1,2,3,4-tetrahydronaphthalene derivatives,their preparation and pharmaceutical compositions containing them | |
ATE100103T1 (de) | 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
ES8300776A1 (es) | Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina | |
ES423395A1 (es) | Procedimiento para la preparacion de derivados de piperazi-na disustituidos en 1,4. | |
FR2342972A2 (fr) | Derives de la purine utilisables comme medicaments pour le traitement d'infections virales | |
ES8202826A1 (es) | Procedimiento para la produccion de una 5,10-dihidroimidazo (2,1-b) quinazolina | |
ES8704477A1 (es) | Procedimiento para preparar piridin-1-oxidos varias veces substituidos | |
ES2031477T3 (es) | Procedimiento para producir esteres de acido 1-hidroxi-5-oxo-5h-pirido/3,2-a/fenoxazin-3-carboxilico. | |
MY104630A (en) | 4(1h) ouinoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8401167-5 Effective date: 19931008 Format of ref document f/p: F |